Biological variability is a major contributor to the inaccuracy of cardiovascular risk assessments based on measurement of lipids, lipoproteins, or apolipoproteins. We obtained estimates of biological variation (CVb) for 20 healthy adults and calculated the percentiles of CVb as an expression of the variability of CVb among individuals for cholesterol, triglyceride, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, apolipoprotein (apo) A-I, apo B, and Iipoprotein(a) [Lp(a)J by four biweekly measurements of these analytes. The
The variability of the measurement of a risk factor for premature coronary artery disease can have a significant impact on the degree of its association with the disease. Thus, those risk factors with high variability could have uncertain estimates of their relationship to coronary artery disease. 
Materials and Methods

Study Protocol
Twenty healthy volunteers, 10 men and 10 women, ages 20 to 52 years, were recruited for this study. All subjects maintained a constant weight and their normal diet and lifestyle during the course of the study. Blood was collected four times from each individual, with a 2-week interval between each sampling. All participants fasted for 12-14 h, and venous blood was collected under standardized conditions between 0800 and 1000 from subjects who had been in a supine position for at least 5 min. From each individual, 40 mL of blood was collected into 10-mL purple-top Vacutainer Tubes (Beeton Dickinson, Rutherford, NJ) containing 10 mg of EDTA and the plasma separated from cells by low-speed centrifugation, quick-frozen without delay, and stored at -70#{176}C. At each of the four visits, an aliquot of the plasma was analyzed fresh in triplicate in the morning and again in triplicate in a separate run in the afternoon. At the end of 8 weeks, frozen plasma samples from each of the four visits were brought to room temperature and mixed gently on a rotator for 5 min; all samples from each participant were analyzed in the same run with samples from each visit analyzed in duplicate. 
Laboratory Methods
Cholesterol
Statistical Methods
The total measurement variability (SD2) is equal to the sum of analytical variability (SDa2) and the natural biological variabifity (SDb2). Variability values can also be expressed in terms of the coefficient of variation (CV) around the test mean. The total intraindividual test variability (CVi) is defined as (CVa2 + CVb); that is,
where CVb is the coefficient of biological variation and CVa is the ccefficient of analytical variation.
Because CVb is computed from CV and CVa, it is important that CVa be accurately estimated. We computed CVa from the variation of the measurements on the participants' samples rather than on quality-control samples and minimized the CVa by analyzing the frozen samples from each participant in the same analytical run. From analysis of the frozen plasma, we computed the SDa for each subject from the formula SDa = Qd2/n -1)', where d is the difference between the number of duplicate measurements, n; n = 4; and the CVa = SDa/(mean of all values for a given subject). From the analyses of the fresh samples, the SDa for each participant was computed from the three values measured in the morning and the three values measured in the afternoon and from the CVa for each individual. Because preliminary analyses indicated that the CVa computed for each subject was independent of the analyte concentration for all analytes except Lp(a), the CVa for each analyte for all participants was computed from the CVa of the analyte values of each subject
where n = 20. This CVa was then used to compute CVb for each subject for each analyte, and the CVb for all subjects was computed as (CVb2/n)1. Table 2 ). The average absolute bias between the values obtained on fresh and frozen plasma was <5% for all analytes ( Table 2 ). The CVb for Lp(a) varied widely among subjects, from 0.9% to 51%, with the participants with the higher Lp(a) concentrations having a lower CVb (Fig. 2) . Therefore, we did not compute the overall CVb for all participants but rather computed CVb for participants in each of four Lp(a) concentration ranges (Table 3) . For the 12 participants with Lp(a) protein <30 mgIL, the CVb estimated Our earlier investigations of the CVb of Lp(a) showed a 7% week-to-week variation in Lp(a) in the few subjects studied (13). In a recent study of 40 subjects, in which Lp(a) was measured three times with a 1-to 2-week interval between each visit, the CVb for Lp(a) was estimated to be only 2.9% (14). The reasons for the differences in the estimates of the biological variation in these two studies and the present study are unclear, but may in part relate to the concentration of Lp(a) in the participants, in view of our finding here that the variation in Lp(a) depends significantly on Lp(a) concentration. Although >90% of the variabffity of apo(a) is deter-mined by the ape(a) gene (15) -11% ). Because Lp(a) concentrations vary more than 1000-fold among subjects, the CVb of Lp(a) is not likely to be a major contributor to the misclassification of a person's risk on the basis of the mean Lp(a) value, unless the value is near the cutoff point.
